ZP
ELDN icon

Zimmer Partners’s Eledon Pharmaceuticals ELDN Stock Holding History

Zimmer Partners’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.78M Sell
1,875,000
-509,228
-21% -$1.2M 0.14% 94
2025
Q4 		$3.6M Buy
2,384,228
+559,228
+31% +$1.33M 0.09% 88
2025
Q3 		$4.73M Buy
1,825,000
+844,318
+86% +$2.47M 0.1% 103
2025
Q2 		$2.66M Buy
980,682
+225,712
+30% +$677K 0.06% 128
2025
Q1 		$2.56M Buy
754,970
+4,970
+0.7% +$20.5K 0.05% 143
2024
Q4 		$3.09M Sell
750,000
-684,727
-48% -$2.7M 0.05% 120
2024
Q3 		$3.57M Sell
1,434,727
-674,977
-32% -$1.81M 0.07% 114
2024
Q2 		$5.57M Buy
+2,109,704
New +$5.04M 0.1% 103

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zimmer Partners's ELDN Position: Q1 2026 in Review

Zimmer Partners reduced its Eledon Pharmaceuticals (ELDN) stake by 21% in Q1 2026, selling an estimated $1.2M and leaving 1,875,000 shares worth $5.78M. The position accounts for 0.14% of the portfolio, ranked #94.

Zimmer Partners first reported a position in ELDN in Q2 2024 and has held it in 8 quarters since. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Zimmer Partners held 1,875,000 shares of Eledon Pharmaceuticals worth $5.78M as of Q1 2026.
  • Zimmer Partners sold 509,228 Eledon Pharmaceuticals shares in Q1 2026, an estimated $1.2M.
  • Eledon Pharmaceuticals made up 0.14% of Zimmer Partners's portfolio in Q1 2026, its #94 holding.
  • Zimmer Partners first reported a position in Eledon Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Zimmer Partners's 13F filing for Q1 2026, filed 15 May 2026.